Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 94,959

Document Document Title
WO/2016/155568A1
Provided are a Streptomyces (Streptomyces hygroscopicus) HS7523 and a method for preparing milbemycin A3 by culturing the Streptomyces. The Streptomyces (Streptomyces hygroscopicus) HS7523 is deposited in "China General Microbiological C...  
WO/2016/160956A1
The present invention relates to compositions to induce production of proteins, e.g., enzymes, e.g., amylases or biomass degrading enzymes in a host cell, and methods for increasing the yield of the proteins, e.g., enzymes produced. Such...  
WO/2016/158653A1
The present invention addresses the problem of providing a novel method for culturing an alga at a low cost and at a high culture efficiency and a medium for algae. Provided is a method for culturing an alga, said method comprising cultu...  
WO/2016/160655A1
In some embodiments, the present disclosure relates to an avian-free egg white composition comprising 45-63% Ovalbumin, 9-15% Ovotransferrin, 0-15% Ovomucoid, 3- 5% Ovoglobulin G2, 3-5% Ovoglobulin G3, 2.5-5% Ovomucin, 3-5% Lysozyme, 1-2...  
WO/2016/159287A1
The method for producing a microbiologic agent according to the present invention comprises: a step for adding, in a medium containing a target compound, an inorganic fine particle carrier and a biomass containing a target compound-degra...  
WO/2016/157130A1
Macroalgae compositions, processes for the preparation thereof, and applications thereof as a sports nutrition supplement are described. More particularly, a macroalgae composition includes a macroalgae extract including medium chain and...  
WO/2016/156164A1
The present invention refers to the strain CECT8836 of Bacillus amyloliquefaciens and mutants thereof, and the use of said strain as a pesticide in controlling plant diseases caused by fungi and bacteria. Further aspects of the invention...  
WO/2016/160936A1
Provided herein, in some aspects, are methods and compositions for cell-free production of ribonucleic acid.  
WO/2016/154771A1
Provided are a synthetic insect-resistant protein and related biological material and application thereof. The insect-resistant protein is represented by A1) or A2). A1): amino acid sequence SEQ ID No. 6. A2): an insect-resistant protein...  
WO/2016/161305A1
A two-vessel continuous flow system in conjunction with low mutation reduced genome bacterial strains provides a platform for long term extended fermentations. Such systems require modification of standard fermentation devices such as pr...  
WO/2016/154665A1
The present invention relates to the handling of biological samples, for example, the holding, manipulating and culturing of biological samples. In one form the invention provides an overlay encapsulant for an in vitro cell culture compr...  
WO/2016/157109A1
The present invention relates to a culture medium specific for microorganisms of Mycoplasma genus and, in particular, for species of hardly cultivable Mycoplasma (Mycoplasma genitalium, Mycoplasma pneumoniae, Mycoplasma penetrans, Mycopl...  
WO/2016/157911A1
Some bacteria can carry out anaerobic respiration by depositing electrons on external materials thereby creating an electrical current. We inoculated microbial fuel cells (MFCs) with microorganisms cultured from a magnet particle enriche...  
WO/2016/159380A1
Provided are a photodegradable hydrogel, a culture device using the same, a method for forming tissue, and a method for separating cells, wherein the photodegradable hydrogel includes a protein as one of the main constituents thereof and...  
WO/2016/159110A1
The present invention addresses the problem of developing and providing a novel gene expression system with which it is possible to improve the expression efficiency of a gene of interest and to individually control the expression of mul...  
WO/2016/160999A1
The present invention provides methods for making microalgal strains with improved properties relative to the strains from which they are derived. In illustrative embodiments, the methods are performed to produce microalgal strains adapt...  
WO/2016/158479A1
Provided are: a freezer for quickly vitrifying a subject to be frozen such as cells by using a spray flow containing ultralow-temperature solid microparticles in freezing so as to achieve a high cell survival rate at thawing; and a freez...  
WO/2016/153247A1
The present invention provides: a Clostridium butyricum strain having immune enhancement and antiviral activities; an immune enhancement and antiviral composition, a probiotic composition, an antibacterial composition and a composition f...  
WO/2016/151092A1
The present invention concerns culture medium for specifically selecting gram-negative, aerobe bacteria that have an acquired resistance to polymyxins as well as bacteria that are naturally resistant to polymyxins. In particular, the cul...  
WO/2016/152440A1
The purpose of the present invention is to provide a bioreactor wherein an organism that conducts photosynthesis in water can be efficiently grown, a growth promotion method, and a material to be used in the aforesaid bioreactor or metho...  
WO/2016/153924A1
The present invention relates to processes for producing ethanol from starch-containing material using a Saccharomyces cerevisiae yeast deposited under Accession No. V15/004035, V15/004036 or V15/004037 at National Measurement Institute,...  
WO/2016/154174A1
Methods of treating contamination, particularly fungal contamination, in cultures of Haematococcus pluvialis with hydrogen peroxide are described herein. The method comprises dosing the culture with a concentration of hydrogen peroxide b...  
WO/2016/152882A1
The purpose of the present invention is to construct a system whereby secretion of procollagen from an animal cells can be detected. This purpose can be achieved by a fusion protein of a fluorescent protein or luminescent protein and a c...  
WO/2016/154046A3
This technology relates in part to biological methods for producing 3-hydroxypropionic acid and engineered microorganisms capable of such production.  
WO/2016/150392A1
Provided are a transformant used for losing weight and reducing fat, and a construction method for the transformant. The transformant is a recombinant lactococcus lactis obtained by replacing a lactococcus lactis thymidylate synthase gen...  
WO/2016/149821A1
A method of preparing a morphinan alkaloid (MA) metabolite comprising: (a) culturing a host cell under conditions suitable for MA production including a first fermentation at a pH of between about 7.5 and about 10, said host cell compris...  
WO/2016/154297A1
The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The p...  
WO/2016/151257A1
The present invention relates to the use of a yeast extract including at least 10 wt % of nucleic acids, preferably at least 15 wt %, and more preferably 30 to 95 wt %, relative to the total weight of said extract, said nucleic acids bei...  
WO/2016/152697A1
The purpose of the present invention is to stably culture a gas-assimilating microorganism, regardless of fluctuations in the supply flow-rate of a substrate gas. In a reaction tank 10, a gas-assimilating microorganism b is cultured in a...  
WO/2016/151656A1
With this aromatic chlorine compound degradation agent characterized by containing Marasmiellus palmivorus and this method for degrading aromatic chlorine compounds by using the aromatic chlorine compound degradation agent, aromatic chlo...  
WO/2016/151545A1
Provided is a method of culturing one or more microorganisms. The method includes culturing one or more microorganisms in a medium comprising crude glycerol at a first concentration level, feeding to the media an additional amount of cru...  
WO/2016/152946A1
Provided is an affinity chromatography carrier in which high immunoglobulin-binding capacity and alkali resistance are maintained. Provided is an immunoglobulin-binding protein, wherein: the immunoglobulin-binding protein contains at lea...  
WO/2016/154314A1
The present invention relates to compositions and methods of producing carotenoids and carotenoid derivatives.  
WO/2016/152828A1
A tien-cha extract essence characterized in being obtained by subjecting a tien-cha extract to an activated carbon treatment, and a method for manufacturing a fermented food item using the tien-cha extract essence provide a technique tha...  
WO/2016/150357A1
Provided are an ophiobolin compound mother nucleus synthetic gene AuOS and application therefor. The gene is derived from Aspergillus ustus 094102, and a gene sequence, a cDNA sequence and an amino acid sequence of an encoding AuOS prote...  
WO/2016/149074A1
The invention provides a novel method for controlling and/or treating the growth of biofilms by promoting growth of the periphery cells and/or increasing nutrient consumption by the periphery cells so that the growth of peripheral cells ...  
WO/2016/148168A1
Provided is a more accurate method of evaluating the capacity of probiotics to be phagocytosed at the cellular level, which is also a method of uniformly evaluating the capacity of probiotics to be phagocytosed, which can easily be perfo...  
WO/2016/147046A1
Provided are novel microalgae that grow rapidly, demonstrate resistance to contamination by other microalgae, have a high lipid content, and have at least a lipid composition that is suitable for the production of biofuel, and a method f...  
WO/2016/149631A3
Provided herein, in some aspects, are methods and compositions for producing large- scale quantities of butanol, including normal butanol (n-butanol), isobutanol, and 2-butanol using a cell-free system.  
WO/2016/147162A1
The present invention relates to PCSK9 inhibitors and methods of use thereof. Specifically, the invention relates to PCSK9 cell-based assay, PCSK9 inhibiting polypeptides and derivatives thereof. The invention includes pharmaceutical com...  
WO/2016/149631A2
Provided herein, in some aspects, are methods and compositions for producing large- scale quantities of butanol, including normal butanol (n-butanol), isobutanol, and 2-butanol using a cell-free system.  
WO/2016/148044A1
The present invention provides modified aminoacyl-tRNA synthetase (ARS) which has improved reactivity with an N-methyl-amino acid compared with naturally occurring aminoacyl-tRNA synthetase. The modified aminoacyl-tRNA synthetase accordi...  
WO/2016/145974A1
Provided is a use of an attenuated gene engineering Salmonella typhimurium strain VPN 20009-M in the preparation of medicaments for preventing and treating cancer metastasis.  
WO/2016/149002A1
In one embodiment, the process combines a fraction (up to 15%) of a lignocellulose substrate with supplemental nutritional material and hydrates the fraction to a moisture content of from 40% to 70% by weight. The hydrated substrate frac...  
WO/2016/143210A1
The organic waste water processing apparatus according to an embodiment comprises an anaerobic processing reactor, a microbe deposit amount-determining mechanism, a flow-controlling mechanism, and a microbe amount-controlling mechanism. ...  
WO/2016/141446A1
The present invention relates to a solid culture medium composition containing specific colouring agents which allow yeasts (starters) inoculated during wine fermentation processes to be identified on the basis of the difference between ...  
WO/2016/143887A1
Provided is an antiallergic agent that can be produced without using heat energy or with relatively reduced usage of heat energy, can relatively reduce the burden of a user upon administration, and is easy to carry when, for example, goi...  
WO/2016/143873A1
[Problem] To provide an improved β-fructofuranosidase which is capable of efficiently producing kestose while inhibiting the production of nystose. [Solution] This improved β-fructofuranosidase comprises either: an amino acid sequence ...  
WO/2016/145378A1
Recombinant microorganisms engineered for the production of polyunsaturated fatty acids (PUFAs) are provided. Also provided are biomass, microbial oils, and food products and ingredients produced by or comprising the microorganisms of th...  
WO/2016/145176A3
Described in this application is a method for producing Plasmodium sporozoites in a cell-free, mosquito-free in vitro culture -system. Compositions and methods resulting from applying the methods of the present invention are described.  

Matches 401 - 450 out of 94,959